JPRN-UMIN000046700已完成未知
Real-world data of immunotherapy in combination with chemotherapy in elderly patients with previously untreated advanced non-small-cell lung cancer: A multicenter retrospective study (NEJ057) - NEJ057
orth East Japan Study Group (NEJSG)0 个研究点目标入组 1,245 人开始时间: 2022年2月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 1,245
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 75years-old 至 ot applicable(—)
- 性别
- All
入选标准
- 未提供
排除标准
- •1 Patients with epidermal growth factor receptor (EGFR) and anaplastic lymphoma kinase (ALK) rearrangement 2 Patients whose attending doctor consider as inappropriate for this study 3 Patients whose first-line systemic therapy was molecular-targeted therapy
研究者
相似试验
招募中
2 期
Combined sublingual immunotherapy VALERGEN-DP and VALERGEN-BT-Asthma-Adults-Phase IIAsthmaBronchial DiseasesLung Diseases, ObstructiveLung DiseasesRespiratory Tract DiseasesRespiratory HypersensitivityHypersensitivity, ImmediateHypersensitivityImmune System DiseasesEnvironmental IllnessRPCEC00000240ational Center of Bioproducts (BIOCEN)120
招募中
不适用
Safety and efficacy of combination immunotherapy with nivolumab and ipilimumab for elderly lung cancer patients: a cohort studynon-small cell lung cancerJPRN-UMIN000046353ational Hospital Organization Kyoto Medical Center60
已完成
1 期
A phase I study of combination immunotherapy with five peptides cocktail, CpG, and immune modulators for patients with advanced or metastatic colorectal cancercolorectal cancerJPRN-UMIN000022082Yamaguchi University12
尚未招募
不适用
Investigate the safety and efficacy of small cell lung cancer,Kidney cancer and Primary liver cancer immunotherapyHistopathologically confirmed small cell lung cancer (SCLC)Histopathologically confirmed Kidney cancerHistopathologically confirmed Liver cancerACTRN12618001337268The First Teaching Hospital, Inner Mongolia Medical University50
已完成
1 期
A combination immunotherapy for the patients with advanced or metastatic solid cancersolid cancerJPRN-UMIN000020440Yamaguchi university Graduate School of Medicine17
